🇺🇸 spironolactone + furosemide in United States

75 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Hyperkalaemia — 10 reports (13.33%)
  2. Renal Failure Acute — 10 reports (13.33%)
  3. Renal Failure — 8 reports (10.67%)
  4. Cardiac Failure — 7 reports (9.33%)
  5. Confusional State — 7 reports (9.33%)
  6. Dehydration — 7 reports (9.33%)
  7. Drug Interaction — 7 reports (9.33%)
  8. Fall — 7 reports (9.33%)
  9. Anaemia — 6 reports (8%)
  10. Dyspnoea — 6 reports (8%)

Source database →

Other Cardiovascular approved in United States

Frequently asked questions

Is spironolactone + furosemide approved in United States?

spironolactone + furosemide does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for spironolactone + furosemide in United States?

Tottori University Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.